Foreign-Trade Zone (FTZ) 7-Mayaguez, Puerto Rico; Notification of Proposed Production Activity; Lilly del Caribe, Inc. (Pharmaceutical Products); Carolina, Puerto Rico

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published

September 16, 2021

Issuing agencies

Commerce DepartmentForeign-Trade Zones Board

Full Text

<html>
<head>
<title>Federal Register, Volume 86 Issue 177 (Thursday, September 16, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 177 (Thursday, September 16, 2021)]
[Notices]
[Pages 51653-51654]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-20000]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-62-2021]


Foreign-Trade Zone (FTZ) 7--Mayaguez, Puerto Rico; Notification 
of Proposed Production Activity; Lilly del Caribe, Inc. (Pharmaceutical 
Products); Carolina, Puerto Rico

    Lilly del Caribe, Inc., submitted a notification of proposed 
production activity to the FTZ Board (the Board) for its facility in 
Carolina, Puerto Rico within Subzone 7K. The notification conforming to 
the requirements of the Board's regulations (15 CFR 400.22) was 
received on September 8, 2021.

[[Page 51654]]

    Pursuant to 15 CFR 400.14(b), FTZ production activity would be 
limited to the specific foreign-status material described in the 
submitted notification (summarized below) and subsequently authorized 
by the Board. The benefits that may stem from conducting production 
activity under FTZ procedures are explained in the background section 
of the Board's website--accessible via <a href="http://www.trade.gov/ftz">www.trade.gov/ftz</a>. The proposed 
material would be added to the production authority that the Board 
previously approved for the operation, as reflected on the Board's 
website.
    The proposed foreign-status material is fluoxetine hydrochloride 
(duty rate 6.5%).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary and sent to: 
<a href="/cdn-cgi/l/email-protection#f99f8d83b98d8b989d9cd79e968f"><span class="__cf_email__" data-cfemail="086e7c72487c7a696c6d266f677e">[email&#160;protected]</span></a>. The closing period for their receipt is October 26, 
2021.
    A copy of the notification will be available for public inspection 
in the ``Online FTZ Information System'' section of the Board's 
website.
    For further information, contact Christopher Wedderburn at 
<a href="/cdn-cgi/l/email-protection#98dbf0eaf1ebb6cffdfcfcfdeafaedeaf6d8eceaf9fcfdb6fff7ee"><span class="__cf_email__" data-cfemail="682b001a011b463f0d0c0c0d1a0a1d1a06281c1a090c0d460f071e">[email&#160;protected]</span></a>.

    Dated: September 10, 2021.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2021-20000 Filed 9-15-21; 8:45 am]
BILLING CODE 3510-DS-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>

View on FederalRegister.gov →Plain-text source

Indexed from Federal Register on September 16, 2021.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.